Literature DB >> 3542182

Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival.

W H Meyer, M J Schell, A P Kumar, B N Rao, A A Green, J Champion, C B Pratt.   

Abstract

Removal of pulmonary metastases of osteosarcoma by thoracotomy is an accepted treatment; however, few investigators have analyzed the value of various prognostic factors in estimating survival. A review of all patients undergoing thoracotomy for recurrent osteosarcoma with pulmonary metastases treated at St. Jude Children's Research Hospital is reported. Since 1968, two thirds (39/59) of all patients who developed pulmonary metastases have had a total of 66 thoracotomies. Nine patients are alive with no evidence of disease, and six additional patients are alive with disease. Analyzed in 39 evaluable patients, the prognostic factors that correlate with survival by univariate analysis are: sex, number of nodules detected radiographically and resected, completeness of resection, and tumor location (bilateral versus unilateral). By Cox regression analysis, only sex and the number of nodules detected either radiographically or during surgery, and resected, had statistically significant correlation with survival. Thoracotomy is curative for some patients with pulmonary metastatic osteosarcoma and Prognostic factors predictive for survival are defined.

Entities:  

Mesh:

Year:  1987        PMID: 3542182     DOI: 10.1002/1097-0142(19870115)59:2<374::aid-cncr2820590235>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign?

Authors:  Peter Brader; Sara J Abramson; Anita P Price; Nicole M Ishill; Zabor C Emily; Chaya S Moskowitz; Michael P La Quaglia; Michelle S Ginsberg
Journal:  J Pediatr Surg       Date:  2011-04       Impact factor: 2.545

2.  Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward.

Authors:  Joanne P Lagmay; Mark D Krailo; Ha Dang; AeRang Kim; Douglas S Hawkins; Orren Beaty; Brigitte C Widemann; Theodore Zwerdling; Lisa Bomgaars; Anne-Marie Langevin; Holcombe E Grier; Brenda Weigel; Susan M Blaney; Richard Gorlick; Katherine A Janeway
Journal:  J Clin Oncol       Date:  2016-07-11       Impact factor: 44.544

3.  In vivo and in vitro investigations on biological effects of aromatic bis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed for chemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. typhimurium.

Authors:  B L Pool; M Berger; J R Schlehofer; F Wingen
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

4.  A 20-year retrospective analysis of CT-based pre-operative identification of pulmonary metastases in patients with osteosarcoma: A single-center review.

Authors:  Todd E Heaton; William J Hammond; Benjamin A Farber; Valerie Pallos; Paul A Meyers; Alexander J Chou; Anita P Price; Michael P LaQuaglia
Journal:  J Pediatr Surg       Date:  2016-10-27       Impact factor: 2.545

5.  Hepatic metastatic disease in pediatric and adolescent solid tumors.

Authors:  Israel Fernandez-Pineda; John A Sandoval; Andrew M Davidoff
Journal:  World J Hepatol       Date:  2015-07-18

6.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

7.  Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma.

Authors:  M P Michelagnoli; I J Lewis; H R Gattamaneni; C C Bailey; L S Lashford
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Osteosarcoma follow-up: chest X-ray or computed tomography?

Authors:  Anna Paioli; Michele Rocca; Luca Cevolani; Eugenio Rimondi; Daniel Vanel; Emanuela Palmerini; Marilena Cesari; Alessandra Longhi; Abate Massimo Eraldo; Emanuela Marchesi; Piero Picci; Stefano Ferrari
Journal:  Clin Sarcoma Res       Date:  2017-02-14

9.  Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies.

Authors:  Sara A Mansfield; Michael Dykes; Brent Adler; Joshua C Uffman; Stephen Sales; Mark Ranalli; Brian D Kenney; Jennifer H Aldrink
Journal:  Pediatr Qual Saf       Date:  2019-06-13

10.  Antitumor Effect of Sclerostin against Osteosarcoma.

Authors:  Hirokazu Ideta; Kazushige Yoshida; Masanori Okamoto; Jun Sasaki; Munehisa Kito; Kaoru Aoki; Yasuo Yoshimura; Shuichiro Suzuki; Atsushi Tanaka; Akira Takazawa; Hisao Haniu; Takeshi Uemura; Takashi Takizawa; Atsushi Sobajima; Takayuki Kamanaka; Jun Takahashi; Hiroyuki Kato; Naoto Saito
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.